China Pharma Holdings Inc
CPHI1.554USD
-0.076-4.66%
終値 11/04, 16:00（ET）15分遅れの株価
5.07M時価総額
損失額直近12ヶ月PER
詳細情報 China Pharma Holdings Inc 企業名
China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. In addition, the Company is also engaged in the production of comprehensive healthcare products and protective products.
China Pharma Holdings Incの企業情報
企業コードCPHI
会社名China Pharma Holdings Inc
上場日Feb 15, 2000
最高経営責任者「CEO」Ms. Zhilin Li
従業員数224
証券種類Ordinary Share
決算期末Feb 15
本社所在地2nd Floor, No. 17, Jinpan Road
都市HAIKOU
証券取引所NYSE American Consolidated
国China
郵便番号570216
電話番号8689866811730
ウェブサイトhttp://www.chinapharmaholdings.com
企業コードCPHI
上場日Feb 15, 2000
最高経営責任者「CEO」Ms. Zhilin Li
China Pharma Holdings Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Zhilin Li
Ms. Zhilin Li
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
302.76K
--
Ms. Heung Mei Tsui
Ms. Heung Mei Tsui
Director
Director
18.63K
--
Mr. Gene Michael Bennett
Mr. Gene Michael Bennett
Independent Director
Independent Director
--
--
Mr. Baowen Dong
Mr. Baowen Dong
Independent Director
Independent Director
--
--
Yingwen Zhang
Yingwen Zhang
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Zhilin Li
Ms. Zhilin Li
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
302.76K
--
Ms. Heung Mei Tsui
Ms. Heung Mei Tsui
Director
Director
18.63K
--
Mr. Gene Michael Bennett
Mr. Gene Michael Bennett
Independent Director
Independent Director
--
--
Mr. Baowen Dong
Mr. Baowen Dong
Independent Director
Independent Director
--
--
Yingwen Zhang
Yingwen Zhang
Independent Director
Independent Director
--
--
収益内訳
通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
事業別USD
会社名
収益
比率
Domestic Pharmaceuticals
1.03M
0.00%
データなし
事業別
地域別
事業別USD
会社名
収益
比率
Domestic Pharmaceuticals
1.03M
0.00%
株主
更新時刻: Sat, Aug 23
更新時刻: Sat, Aug 23
株主統計
種類
株主統計
株主統計
比率
Li (Zhilin)
9.28%
Liu (Tao Chengdu)
9.20%
UBS Financial Services, Inc.
2.18%
Citadel Advisors LLC
0.71%
Tsui (Heung Mei)
0.57%
他の
78.06%
株主統計
株主統計
比率
Li (Zhilin)
9.28%
Liu (Tao Chengdu)
9.20%
UBS Financial Services, Inc.
2.18%
Citadel Advisors LLC
0.71%
Tsui (Heung Mei)
0.57%
他の
78.06%
種類
株主統計
比率
Individual Investor
19.05%
Investment Advisor
2.68%
Hedge Fund
0.96%
他の
77.31%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
14
118.68K
3.64%
+73.43K
2025Q2
18
721.01K
22.10%
+60.71K
2025Q1
21
1.02M
31.30%
+60.71K
2024Q4
21
10.05M
52.18%
+471.51K
2024Q3
20
9.91M
65.84%
+3.60M
2024Q2
20
9.93M
65.98%
+3.66M
2024Q1
18
9.99M
66.39%
+3.80M
2023Q4
16
6.74M
97.18%
+3.36M
2023Q3
16
3.69M
42.02%
+3.06M
2023Q2
16
907.22K
57.28%
+262.90K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Li (Zhilin)
302.76K
9.28%
--
--
Mar 24, 2025
Liu (Tao Chengdu)
300.00K
9.2%
--
--
Mar 24, 2025
UBS Financial Services, Inc.
71.23K
2.18%
+60.78K
+581.79%
Jun 30, 2025
Citadel Advisors LLC
23.07K
0.71%
+17.76K
+334.79%
Jun 30, 2025
Tsui (Heung Mei)
18.63K
0.57%
--
--
Mar 24, 2025
HRT Financial LP
16.17K
0.5%
+13.66K
+543.89%
Jun 30, 2025
Tower Research Capital LLC
8.21K
0.25%
+8.21K
--
Jun 30, 2025
Two Sigma Investments, LP
--
0%
-2.53K
-100.00%
Jun 30, 2025
XTX Markets LLC
--
0%
-8.38K
-100.00%
Jun 30, 2025
Citi Investment Research (US)
--
0%
-533.00
-100.00%
Mar 31, 2025
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Feb 24, 2023
Merger
10→1
Feb 24, 2023
Merger
10→1
日付
種類
比率
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Dec 20, 2023
Merger
5→1
Feb 24, 2023
Merger
10→1
Feb 24, 2023
Merger
10→1
Feb 24, 2023
Merger
10→1
Feb 24, 2023
Merger
10→1
